Skip to content

    Ovarian Cancer Health Center

    Font Size
    A
    A
    A

    Test May Help Predict Survival From Ovarian Cancer

    Method was used to count special type of immune cells in tumors from 30 women in study

    WebMD News from HealthDay

    By Steven Reinberg

    HealthDay Reporter

    WEDNESDAY, Dec. 4 (HealthDay News) -- By counting the number of cancer-fighting immune cells inside tumors, scientists say they may have found a way to predict survival from ovarian cancer.

    The researchers developed an experimental method to count these cells, called tumor-infiltrating T lymphocytes (TILs), in women with early stage and advanced ovarian cancer.

    "We have developed a standardizable method that should one day be available in the clinic to better inform physicians on the best course of cancer therapy, therefore improving treatment and patient survival," said lead researcher Jason Bielas, at the Fred Hutchinson Cancer Research Center, in Seattle.

    The test may have broader implications beyond ovarian cancer and be useful with other types of cancer, the study authors suggested.

    In their current work with ovarian cancer patients, the researchers "demonstrated that this method can be used to diagnose T-cells quickly and effectively from a blood sample," said Bielas, an associate member in human biology and public health sciences.

    The report was published online Dec. 4 in Science Translational Medicine.

    The researchers developed the test to count TILs, identify their frequency and develop a system to determine their ability to clone themselves. This is a way of measuring the tumor's population of immune T-cells.

    The test works by collecting genetic information of proteins only found in these cells.

    "T-cell clones have unique DNA sequences that are [comparable] to product barcodes on items at the grocery store. Our technology is comparable to a barcode scanner," Bielas said.

    The technique, called QuanTILfy, was tested on tumor samples from 30 women with ovarian cancer whose survival ranged from one month to about 10 years.

    Bielas and colleagues looked at the number of TILs in the tumors, comparing those numbers to the women's survival.

    The researchers found that higher TIL levels were linked with better survival. For example, the percent of TILs was about three times higher in women who survived more than five years than in those who survived less than two years.

    "We are hoping to investigate whether this is a general phenomena of all cancers," Bielas said. "There is good evidence now that the same associations can be made for melanoma and colorectal cancer."

    Today on WebMD

    Ovarian cancer illustration
    What are the symptoms?
    doctory with x-ray
    Get to know the Symptoms.
     
    cancer cell
    HPV is the top cause. Find out more.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    Integrative Medicine Cancer Quiz
    QUIZ
    Lifestyle Tips for Depression Slideshow
    SLIDESHOW
     
    Screening Tests for Women
    Slideshow
    Graphic of ovaries within reproductive system
    VIDEO
     
    Ovarian Cancer Marker
    VIDEO
    Pets Improve Your Health
    SLIDESHOW
     
    Vitamin D
    SLIDESHOW
    Healthy meal with salmon
    Article